Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- Drug: BETAXON (levobetaxolol HCl)
- First Posted Date
- 2003-05-30
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 78
- Registration Number
- NCT00061516
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- GlaucomaOcular Hypertension
- First Posted Date
- 2003-05-30
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00061503
- Locations
- ๐บ๐ธ
Alcon Call Center, Call for Details, Nebraska, United States
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- First Posted Date
- 2003-05-30
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00061529
- Locations
- ๐บ๐ธ
Alcon Call Center, Fort Worth, Texas, United States
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
Phase 3
Completed
- Conditions
- Macular DegenerationMaculopathy, Age-Related
- First Posted Date
- 2003-04-16
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00058994
- Locations
- ๐บ๐ธ
South America, Fort Worth, Texas, United States
A Long-term Safety Study of Once-daily Travatan
- First Posted Date
- 2003-01-07
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 502
- Registration Number
- NCT00051168
- Locations
- ๐บ๐ธ
Europe, Fort Worth, Texas, United States
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)
Phase 3
Completed
- Conditions
- Macular DegenerationMaculopathy, Age-RelatedAge-Related MaculopathiesAge-Related MaculopathyMaculopathies, Age-Related
- Interventions
- Other: Anecortave Acetate Vehicle
- First Posted Date
- 2003-01-07
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 291
- Registration Number
- NCT00051129
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Glaucoma, Open-angleOcular Hypertension
- First Posted Date
- 2003-01-07
- Last Posted Date
- 2012-04-16
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00051194
- Locations
- ๐บ๐ธ
Europe, Fort Worth, Texas, United States
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
Phase 3
Completed
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- First Posted Date
- 2003-01-07
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00051155
- Locations
- ๐บ๐ธ
Europe, Fort Worth, Texas, United States
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
Phase 3
Completed
- Conditions
- Glaucoma, Angle-ClosureOcular Hypertension
- First Posted Date
- 2003-01-07
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00051181
- Locations
- ๐บ๐ธ
Asia, Fort Worth, Texas, United States
๐ฆ๐บAustralia, Sidney, Australia
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Phase 3
Completed
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- First Posted Date
- 2003-01-07
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00051142
- Locations
- ๐บ๐ธ
Latin America, Fort Worth, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath